Early administration of COVID-19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacy

the Broad Institute COVID-19 Antibody Team

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Early administration of COVID-19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacy'. Together they form a unique fingerprint.

Medicine & Life Sciences